Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Abstract Background and Objective ABP 654 is a proposed biosimilar to ustekinumab reference product (RP), a human immunoglobulin isotype class G subclass 1 kappa monoclonal antibody that acts as an antagonist of interleukin (IL)-23 and IL-12. Ustekinumab RP is indicated for the treatment of some for...
Saved in:
Main Authors: | Greg Cantin (Author), Qian Liu (Author), Bhavana Shah (Author), Scott Kuhns (Author), Mats Wikström (Author), Shawn Cao (Author), Jennifer Liu (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis
by: Dong Liu, et al.
Published: (2024) -
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
by: Di Cao, et al.
Published: (2023) -
A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects
by: Lei Gao, et al.
Published: (2021) -
Comparative Analytical Evaluation of the Proposed Biosimilar FYB206 and its Reference Medicinal Product Keytruda®
by: Jakob C. Stüber, et al.
Published: (2024) -
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
by: Yijia Jiang, et al.
Published: (2023)